Tejnaksh Healthcare Share Price

Tejnaksh Healthcare Limited was incorporated in Mumbai as Tejnaksh Healthcare Private Limited on 18 February, 2008 as a Private Limited Company. Company was converted to a Public Limited Company and the name was changed to Tejnaksh Healthcare Limited vide fresh Certificate of Incorporation dated 10 March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.The Company run an Institute of Urology, an ISO certified the international level Urology hospital, located in Dhule, Maharashtra. It provides a comprehensive range of services from consultations and investigations to treatment for Urology. The main objective of Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. Initiated with a vision to strengthen healthcare in rural India, the Company started its journey from Institute of Urology, a state of the art flagship, kidney care center in Dhule in the year 2003. A recognized teaching institute by the Ministry of Health and Family welfare, the Company provides quality healthcare services at 13 urology clinics, 4 urology hospitals and 2 dental super specialty clinics. The Companys achievements were the multiple records that motivates the customers to improve treatment for Urology.In 2005, the Company started the 1st Urodynamics Lab of North Maharashtra. In 2006 , it established First Urology CME for the amily physicians. In 2007, it set up 1st Laser Unit and 1st Flexible Ureteroscope of North Maharashtra. In 2009, the Company was into Urology and healthcare training, recognized by The National Board of Examination. In October 2015, the Company made a public issue of 3,04,000 Equity Shares of Rs 10/ each by raising funds aggregating to Rs. 2.44 Crores. In 2015, the Company hosted the first PCNL workshop and became a public limited company. During the same year, the Company first dental speciality clinic took the initiative to set up The International Health Tourism. In 2016, the Company set up the first indigenous PCNL simulation lab in the country and were made commercially available during the year. The Company started Urology and Dental centers at Malegaon (MS), Sendhwa (MP) and a multispeciality center in Navi Mumbai in 2016.

For the full year FY2025–2026, revenue reached ₹13.3 crore and profit touched at ₹2.23 crore.

As of 19 Sep, 2025, Tejnaksh Healthcare share price is ₹18.6. The stock opened at ₹18.5 and had closed at ₹18.5 the previous day. During today’s trading session, Tejnaksh Healthcare share price moved between ₹18.30 and ₹18.55, with an average price for the day of ₹18.43. Over the last 52 weeks, the stock has recorded a low of ₹17.80 and a high of ₹29.50. In terms of performance, Tejnaksh Healthcare share price has declined by 20.4% over the past six months and has declined by 26.62% over the last year.